Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.11B |
| 2 |
Snowflake
SNOW
|
+$1.67B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.61B |
| 4 |
Shopify
SHOP
|
+$1.42B |
| 5 |
Royalty Pharma
RPRX
|
+$1.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$2.27B |
| 2 |
Amazon
AMZN
|
+$2.09B |
| 3 |
Vipshop
VIPS
|
+$1.28B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.27B |
| 5 |
Alibaba
BABA
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Healthcare | 9.78% |
| 3 | Financials | 9.01% |
| 4 | Communication Services | 8.96% |
| 5 | Consumer Discretionary | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RYZ
3051
Ryerson Holding Corp
RYZ
$1.5B
| $6.76M | ﹤0.01% |
396,880
+65,703
| +20% | +$983K |
|
3052
Healthcare Services Group
HCSG
$1.48B
| $6.76M | ﹤0.01% |
241,186
+90,973
| +61% | +$2.75M |
|
3053
Imperial Oil
IMO
$64.5B
| $6.75M | ﹤0.01% |
279,313
+98,219
| +54% | +$2.17M |
|
3054
Bain Capital Specialty
BCSF
$814M
| $6.75M | ﹤0.01% |
456,929
+15,158
| +3% | +$209K |
|
|
JEMD
3055
DELISTED
Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share
JEMD
| $6.75M | ﹤0.01% |
854,712
+134,299
| +19% | +$1.05M |
|
|
PPT
3056
Franklin Premier Income Trust
PPT
$331M
| $6.75M | ﹤0.01% |
1,385,804
-341,105
| -20% | -$1.61M |
|
|
GRFS
3057
Grifois
GRFS
$5.29B
| $6.73M | ﹤0.01% |
389,483
+191,959
| +97% | +$3.32M |
|
3058
Stagwell
STGW
$2.23B
| $6.73M | ﹤0.01% |
2,155,739
-11,308
| -0.5% | -$34.4K |
|
|
LFC
3059
DELISTED
China Life Insurance Company Ltd.
LFC
| $6.72M | ﹤0.01% |
645,334
+320,457
| +99% | +$3.47M |
|
|
BTEC
3060
DELISTED
Principal Exchange-Traded Funds Principal Healthcare Innovators ETF
BTEC
| $6.71M | ﹤0.01% |
115,937
+115,511
| +27,115% | +$7.23M |
|
3061
Graham Holdings Company
GHC
$5.04B
| $6.71M | ﹤0.01% |
11,922
-2,154
| -15% | -$1.25M |
|
3062
Columbia Sportswear
COLM
$2.94B
| $6.69M | ﹤0.01% |
63,324
+9,636
| +18% | +$953K |
|
3063
KBR
KBR
$4.84B
| $6.69M | ﹤0.01% |
174,181
-86,311
| -33% | -$2.75M |
|
3064
Dillards
DDS
$8.76B
| $6.68M | ﹤0.01% |
69,184
-416,648
| -86% | -$33.8M |
|
|
SRNE
3065
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $6.67M | ﹤0.01% |
805,985
-1,141,908
| -59% | -$12.1M |
|
3066
Cimpress
CMPR
$2.3B
| $6.67M | ﹤0.01% |
66,568
-10,666
| -14% | -$1.05M |
|
3067
First Industrial Realty Trust
FR
$8.33B
| $6.67M | ﹤0.01% |
145,560
-363,434
| -71% | -$15.7M |
|
|
GLO
3068
Clough Global Opportunities Fund
GLO
$257M
| $6.67M | ﹤0.01% |
544,145
+46,890
| +9% | +$575K |
|
|
ATRS
3069
DELISTED
Antares Pharma, Inc.
ATRS
| $6.67M | ﹤0.01% |
1,621,499
+996,992
| +160% | +$4.32M |
|
3070
Ingles Markets
IMKTA
$1.65B
| $6.66M | ﹤0.01% |
108,011
+26,284
| +32% | +$1.38M |
|
|
DCH
3071
Dauch Corp
DCH
$1.6B
| $6.65M | ﹤0.01% |
688,249
-267,523
| -28% | -$2.65M |
|
3072
Invesco S&P SmallCap Consumer Discretionary ETF
PSCD
$24.3M
| $6.65M | ﹤0.01% |
59,234
+28,849
| +95% | +$2.95M |
|
3073
Monro
MNRO
$359M
| $6.64M | ﹤0.01% |
100,933
-33,284
| -25% | -$2.08M |
|
|
PCH
3074
DELISTED
PotlatchDeltic
PCH
| $6.63M | ﹤0.01% |
125,310
-70,569
| -36% | -$3.64M |
|
|
RJET
3075
Republic Airways Holdings
RJET
$952M
| $6.63M | ﹤0.01% |
32,851
+10,637
| +48% | +$1.67M |
|
Similar funds
Morgan Stanley's Q1 2021 Portfolio in Review
As of Q1 2021, Morgan Stanley held 7,749 positions worth $681B, up 5.1% from $647B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q1 2021 filing shows 618 new, 3,173 increased, 3,213 reduced and 189 closed positions. Its largest new stake was Coupang: 16,573,913 shares worth $818M. The largest sale was Paramount Global Class B, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2021 buy was Coupang: 16,573,913 shares worth $818M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $3.11B increase.
- Morgan Stanley's biggest Q1 2021 reduction was Paramount Global Class B, cutting an estimated $2.27B.
- Morgan Stanley fully exited Tiffany & Co. in Q1 2021, selling an estimated $318M.
- Morgan Stanley's ten largest holdings make up 16% of its $681B portfolio in Q1 2021.
- Morgan Stanley opened 618 new positions and closed 189 in Q1 2021.
- Morgan Stanley's portfolio value rose 5.1% quarter-over-quarter to $681B.
Based on Morgan Stanley's 13F filing for Q1 2021, filed 17 May 2021.